Robert Arch, PhD (President) will be attending BIO-Europe 2025 in Vienna, Austria, November 3-5.

As one of the premier partnering conferences for the global biotech industry, BIO-Europe offers a unique opportunity to connect, collaborate, and explore the future of life sciences innovation. He is looking forward to an inspiring few days at BIO-Europe.

If you’re planning to attend, be sure to connect with Robert to discuss recent progress in Immunophotonics’ pioneering efforts in Interventional Immuno-Oncology® intended to reduce tumor recurrence after standard-of-care local ablation therapy, which is one of the most significant unmet medical needs today.